R
Robert Langer
MIT Institute Professor and biomedical engineering pioneer; co-founder of Moderna and 40+ biotech companies, known as the "Edison of Medicine."
6
APPEARANCES
6
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
NOV 9
NOV 16
Sep 11, 2026
Dr. Robert Langer
5:01
5:08
5:15
5:23
5:33
5:39
15:56
Jessica HarrisHOST
What was the landscape of biomaterials when you were pioneering this field in the 1970s? Yeah,

Robert LangerGUEST
Most biomaterials that people used in the body were largely driven by medical doctors, clinicians.

Robert LangerGUEST
And what they do is they would often go to their house and find an object that would kind of resemble the organ or tissue they wanted to fix.

Robert LangerGUEST
So just to give a few examples, the material in the artificial heart, that was a lady's girdle material because it had a good, you know, good buoyancy or flex life.

Robert LangerGUEST
And the material in a breast implant, that was actually, one of them was actually a mattress stuffing because it was the right squishiness.

Robert LangerGUEST
The material in a, what's called a vascular graft, an artificial blood vessel, that was a surgeon going to a clothes store and finding something they could sew well with.
10 MINS LATER
Jessica HarrisHOST
What are some of the hurdles that you've faced entrepreneurially, even outside of the development of your lab in the early days in the 1980s?
An Interview with A Mentor- Dr. Robert Langer, Sc.D. (MIT Institute Professor) on aspects of the Future of Diabetes Medicine Research
2:04
D
1:52DavidHOST
So the first question is, Bob, can multi-receptor pharmacology and smart delivery be unified? Are they best kept separate?

Robert LangerGUEST
I think it's, you know, I, I think really the idea of, well, in general, a theranostic, you know, a, a, a system that can diagnose things and tell you what to do, I think is a good idea.
6 MINS LATER
D
8:41DavidHOST
Yeah
An Interview with A Mentor- Dr. Robert Langer, Sc.D. (MIT Institute Professor) on aspects of the Future of Diabetes Medicine Research
1:52
2:04

D.J. FergusonHOST
So the first question is, Bob, can multi-receptor pharmacology and smart delivery be unified? Are they best kept separate?

Robert LangerGUEST
I think it's, you know, I, I think really the idea of, well, in general, a theranostic, you know, a, a, a system that can diagnose things and tell you what to do, I think is a good idea.
7 MINS LATER
Mentorship in Motion: Six Years of Learning with A Leading Chemical Engineer Dr. Robert Langer—Guiding Science from Lab to World (2020-2026)
16:36
16:44
16:51
17:02

David FergusonHOST
What has been the, what has kept you optimistic during this time, during this pandemic? What has kept you optimistic?

Robert LangerGUEST
One of the things that we're, I've been doing is I've been spending a lot of time trying to fight this pandemic.

Robert LangerGUEST
You know, one of the companies I helped start is Moderna, and Moderna's been one of the leading companies in terms of creating the COVID vaccine.

Robert LangerGUEST
And actually, almost every one of the companies that's doing, uh, an RNA vaccine, and those are the leading ones in terms of moving forward in the clinic, uses nanoparticles, uh, you know, which is an area to, to deliver the RNA.
46 MINS LATER
S
63:39speaker_6NARRATOR
Here are some of Bob's responses to those questions.
Mentorship in Motion: Six Years of Learning with A Leading Chemical Engineer Dr. Robert Langer—Guiding Science from Lab to World (2020-2026)
16:37
16:44
16:53

David FergusonHOST
What has kept you optimistic during this time, during this pandemic? What has kept you optimistic?

Robert LangerGUEST
One of the things that we're, I've been doing is I've been spending a lot of time trying to fight this pandemic.

Robert LangerGUEST
Moderna has been one of the leading companies in terms of creating the COVID vaccine.
47 MINS LATER
S
63:39speaker_6UNKNOWN
Here are some of Bob's responses to those questions.
Covid Vaccine Pioneer, Bob Langer: Turning Science Into Billion Dollar Ideas
9:59
10:13
10:24

Robert LangerGUEST
Well, I actually feel that it's still I mean, how should I say this? The downside that people might say is that if you have patents, then that prevents other people from doing things.

Robert LangerGUEST
The problem in the medical area is you won't have to worry about people It just goes back to the example I gave you.

Robert LangerGUEST
I mean, I can't imagine any investors have a choice, right? I'll pick the United States.
6 MINS LATER
